Stock Report

Divis Laboratories Ltd posts Rs. 348 crores consolidated net profit in Q2 FY2024

Posted On : 2023-11-06 15:32:13( TIMEZONE : IST )

Divi's Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2023.

Financial Results (Q2 FY2024) - QoQ Comparison

The company has reported total income of Rs. 1995 crores during the period ended September 30, 2023 as compared to Rs. 1859 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs. 348 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 356 crores for the period ended June 30, 2023.

The company has reported EPS of Rs. 13.11 for the period ended September 30, 2023 as compared to Rs. 13.41 for the period ended June 30, 2023.

Financials	Q2 FY2024	Q1 FY2024	% Change
Total Income	₹ 1995 crs	₹1859 crs	7.32%
Net Profit	₹348 crs	₹356 crs	-2.25%
EPS	₹13.11	₹13.41	-2.24%

Financial Results (Q2 FY2024) - YoY Comparison

The company has reported total income of Rs. 1995 crores during the period ended September 30, 2023 as compared to Rs.1935 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.348 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.493 crores for the period ended September 30, 2022.

The company has reported EPS of Rs.13.11 for the period ended September 30, 2023 as compared to Rs.18.60 for the period ended September 30, 2022.

Financials	Q2 FY2024	Q2 FY2023	% Change
Total Income	₹ 1995 crs	₹1935 crs	3.10%
Net Profit	₹348 crs	₹493 crs	-29.41%
EPS	₹13.11	₹18.60	-29.52%

Financial Results (Half Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.3854 crores during the 6 Months period ended September 30, 2023 as compared to Rs.4278 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.704 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.1196 crores for the 6 Months period ended September 30, 2022.

The company has reported EPS of Rs.26.52 for the 6 Months period ended September 30, 2023 as compared to Rs.45.04 for the 6 Months period ended September 30, 2022.

Financials	Half Year Ended FY2024	Half Year Ended FY2023	% Change
Total Income	₹3854 crs	₹4278 crs	-9.91%
Net Profit	₹704 crs	₹1196 crs	-41.14%
EPS	₹26.52	₹45.04	-41.12%

Shares of Divi's Laboratories Limited was last trading in BSE at Rs. 3349.90 as compared to the previous close of Rs. 3344.25. The total number of shares traded during the day was 11773 in over 1832 trades.

The stock hit an intraday high of Rs. 3387.10 and intraday low of 3339.75. The net turnover during the day was Rs. 39601300.00.